Cardiac pacing for vasovagal syncope: a reasonable therapeutic option?

Area of Science:

• Cardiology
• Neuroscience
• Medical Devices

Background:

• Vasovagal syncope is a common condition characterized by a sudden drop in heart rate and blood pressure, leading to fainting.
• Cardiac pacing is a potential intervention explored for preventing syncope episodes.
• The underlying mechanisms of vasovagal syncope, including the vasodepressor and cardioinhibitory components, influence treatment efficacy.

Purpose of the Study:

• To evaluate the effectiveness of cardiac pacing in preventing tilt-induced vasovagal syncope.
• To determine if cardiac pacing can reduce the frequency and severity of syncope episodes.
• To assess the long-term outcomes of cardiac pacing in patients experiencing recurrent vasovagal syncope.

Main Methods:

• Review of existing studies on cardiac pacing for vasovagal syncope prevention.
• Analysis of findings regarding the impact of pacing on syncope onset and presyncopal symptoms.
• Examination of data from a large retrospective assessment of pacing efficacy in patients with vasovagal syncope.

Main Results:

• Cardiac pacing generally does not prevent the onset of vasovagal syncope.
• Hypotension, a vasodepressor effect, typically precedes bradycardia, making pacing less effective for prevention.
• Dual-chamber pacing may prolong the presyncopal period in patients with a significant cardioinhibitory component.
• A retrospective assessment showed 89% of patients reported improved symptoms, with 62% remaining recurrence-free over 50 months.

Conclusions:

• Cardiac pacing is not a primary prevention strategy for vasovagal syncope due to its pathophysiology.
• Dual-chamber pacing might offer symptomatic benefit by prolonging the presyncopal phase in specific patient subgroups.
• While not preventing syncope, pacing demonstrated significant long-term symptom improvement and recurrence reduction in a large patient cohort.